Intrinsic Value of S&P & Nasdaq Contact Us

Akoya Biosciences, Inc. AKYA NASDAQ

NASDAQ Global Select • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
41/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$2.40
+86%

Akoya Biosciences, Inc. (AKYA) has 16 known insider and institutional holders on record. The largest holder is McKelligon Brian with 420,126 shares. Other notable holders include Ramachandran Niro Ph.D and Ek John Frederick.

Over the last 12 months, insiders have made 1 transactions in AKYA stock — 0 buys (valued at RSU Award) and 0 sells (valued at RSU Award).

AKYA Insider Ownership

Top Holder
McKelligon Brian
420,126 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
12-Month Transaction Activity
Buy 0%
Sell 0%
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Mckelligon Brian President and CEO 420,126 2025-03-25
100%
2 Ramachandran Niro Ph.d Chief Business Officer 287,210 2025-03-25
68%
3 Ek John Frederick CFO 248,202 2025-04-03
59%
4 Bamford Pascal Chief Clinical Officer 205,738 2025-06-02
49%
5 Kamocsay Jennifer Chief Legal Officer 179,272 2025-03-04
43%
6 Driscoll Joseph Chief Financial Officer 110,958 2022-12-27
26%
7 Pla Frederic Chief Operating Officer 101,500 2024-03-25
24%
8 Nolan Garry Ph.d. Director 56,322 2023-06-05
13%
9 Lai Goldman Myla Director 50,000 2024-06-05
12%
10 Schnettler Thomas P Director 50,000 2024-06-05
12%
11 Winkler Matthew Director 50,000 2024-06-05
12%
12 Shepler Robert G Director 50,000 2024-06-05
12%
13 Raffin Thomas A. Director 50,000 2024-06-05
12%
14 Mendel Scott Director 44,959 2024-10-04
11%
15 Moy Marilee Chief People Officer 20,000 2023-02-27
5%
16 El-gabry Ehab Chief Medical Officer 16,250 2023-02-27
4%
Recent Transactions (last 12 months)
Date Name Role Type Shares Price Value
2025-06-01 Bamford Pascal Chief Clinical Officer Tax Withholding of RSU 670 $1.25 $837.50
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message